112 related articles for article (PubMed ID: 10425361)
1. Distribution characteristics of entrapped recombinant human erythropoietin in liposomes and its intestinal absorption in rats.
Maitani Y; Moriya H; Shimoda N; Takayama K; Nagai T
Int J Pharm; 1999 Aug; 185(1):13-22. PubMed ID: 10425361
[TBL] [Abstract][Full Text] [Related]
2. Oral administration of recombinant human erythropoietin in liposomes in rats: influence of lipid composition and size of liposomes on bioavailability.
Maitani Y; Hazama M; Tojo Y; Shimoda N; Nagai T
J Pharm Sci; 1996 Apr; 85(4):440-5. PubMed ID: 8901085
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic and pharmacological profiles of free and liposomal recombinant human erythropoietin after intravenous and subcutaneous administrations in rats.
Moriya H; Maitani Y; Shimoda N; Takayama K; Nagai T
Pharm Res; 1997 Nov; 14(11):1621-8. PubMed ID: 9434284
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic and pharmacodynamic studies following oral administration of erythropoietin mucoadhesive tablets to beagle dogs.
Venkatesan N; Yoshimitsu J; Ohashi Y; Ito Y; Sugioka N; Shibata N; Takada K
Int J Pharm; 2006 Mar; 310(1-2):46-52. PubMed ID: 16439074
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of liposomal erythropoietin prepared with reverse-phase evaporation vesicle method by subcutaneous administration in rats.
Qi XR; Maitani Y; Shimoda N; Sakaguchi K; Nagai T
Chem Pharm Bull (Tokyo); 1995 Feb; 43(2):295-9. PubMed ID: 7728935
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic and pharmacodynamic studies following percutaneous absorption of erythropoietin micropiles to rats.
Ito Y; Shiroyama K; Yoshimitsu J; Ohashi Y; Sugioka N; Takada K
J Control Release; 2007 Aug; 121(3):176-80. PubMed ID: 17628163
[TBL] [Abstract][Full Text] [Related]
7. Erythropoietin acts as a trophic factor in neonatal rat intestine.
Juul SE; Ledbetter DJ; Joyce AE; Dame C; Christensen RD; Zhao Y; DeMarco V
Gut; 2001 Aug; 49(2):182-9. PubMed ID: 11454792
[TBL] [Abstract][Full Text] [Related]
8. Gastro-intestinal patch system for the delivery of erythropoietin.
Venkatesan N; Uchino K; Amagase K; Ito Y; Shibata N; Takada K
J Control Release; 2006 Mar; 111(1-2):19-26. PubMed ID: 16377018
[TBL] [Abstract][Full Text] [Related]
9. Effects of dose, pH and osmolarity on intranasal absorption of recombinant human erythropoietin in rats.
Shimoda N; Maitani Y; Machida Y; Nagai T
Biol Pharm Bull; 1995 May; 18(5):734-9. PubMed ID: 7492992
[TBL] [Abstract][Full Text] [Related]
10. Effect of fiber length of carbon nanotubes on the absorption of erythropoietin from rat small intestine.
Ito Y; Venkatesan N; Hirako N; Sugioka N; Takada K
Int J Pharm; 2007 Jun; 337(1-2):357-60. PubMed ID: 17270373
[TBL] [Abstract][Full Text] [Related]
11. Distribution of recombinant human erythropoietin following multiple intravenous administration and effects of age on the distribution in rats.
Kinoshita H; Ohishi N; Kato M; Tokura S; Okazaki A
Arzneimittelforschung; 1992 Apr; 42(4):579-84. PubMed ID: 1642686
[TBL] [Abstract][Full Text] [Related]
12. Reticulocyte changes after experimental anemia and erythropoietin treatment of horses.
Cooper C; Sears W; Bienzle D
J Appl Physiol (1985); 2005 Sep; 99(3):915-21. PubMed ID: 16103516
[TBL] [Abstract][Full Text] [Related]
13. Effects of orally administered liposomes with soybean-derived sterols and their glucosides on rat body weight.
Maitani Y; Hazama M; Tojo H; Qi XR; Nagai T
Biol Pharm Bull; 1995 Nov; 18(11):1551-5. PubMed ID: 8593478
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic and pharmacodynamic studies on recombinant human erythropoietin.
Salmonson T
Scand J Urol Nephrol Suppl; 1990; 129():1-66. PubMed ID: 2255869
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and effectiveness of recombinant erythropoietin administered to preterm infants by continuous infusion in total parenteral nutrition solution.
Ohls RK; Veerman MW; Christensen RD
J Pediatr; 1996 Apr; 128(4):518-23. PubMed ID: 8618186
[TBL] [Abstract][Full Text] [Related]
16. Effect of intravenous iron supplementation on erythropoiesis in erythropoietin-treated premature infants.
Pollak A; Hayde M; Hayn M; Herkner K; Lombard KA; Lubec G; Weninger M; Widness JA
Pediatrics; 2001 Jan; 107(1):78-85. PubMed ID: 11134438
[TBL] [Abstract][Full Text] [Related]
17. Liquid filled nanoparticles as a drug delivery tool for protein therapeutics.
Venkatesan N; Yoshimitsu J; Ito Y; Shibata N; Takada K
Biomaterials; 2005 Dec; 26(34):7154-63. PubMed ID: 15967493
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of intraperitoneal, intravenous, and subcutaneous recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis.
Ateshkadi A; Johnson CA; Oxton LL; Hammond TG; Bohenek WS; Zimmerman SW
Am J Kidney Dis; 1993 Jun; 21(6):635-42. PubMed ID: 8503418
[TBL] [Abstract][Full Text] [Related]
19. Comparative pharmacokinetics and distribution of human urinary erythropoietin and recombinant human erythropoietin in rats.
Kinoshita H; Ohishi N; Kato M; Tokura S; Okazaki A
Arzneimittelforschung; 1991 Sep; 41(9):1004-7. PubMed ID: 1796912
[TBL] [Abstract][Full Text] [Related]
20. Effects of recombinant human erythropoietin on megakaryocytes and on platelet production in the rat.
Berridge MV; Fraser JK; Carter JM; Lin FK
Blood; 1988 Sep; 72(3):970-7. PubMed ID: 3416080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
